Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
6.35
+0.05 (0.79%)
Jun 23, 2026, 10:34 AM EDT - Market open
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $3.38 million as of June 23, 2026. Its market cap has increased by 119.77% in one year.
Market Cap
3.38M
Enterprise Value
-4.47M
1-Year Change
119.77%
Ranking
Category
Stock Price
$6.35
Market Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.18M to $3.38M, a decrease of -92.35%. That is a compound annual growth rate of -31.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 3.38M | -18.45% |
| Dec 31, 2025 | 4.14M | 56.21% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.55% |
| Dec 30, 2022 | 3.49M | -84.43% |
| Dec 31, 2021 | 22.39M | 3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 3.88M |
| Matinas BioPharma Holdings | 3.87M |
| Revelation Biosciences | 3.83M |
| Galmed Pharmaceuticals | 3.82M |
| Onconetix | 3.48M |
| Virax Biolabs Group | 3.45M |
| VivoSim Labs | 3.18M |
| Azitra | 2.78M |